Inflammation and its genesis in cystic fibrosis

Pediatric Pulmonology
David P Nichols, James F Chmiel

Abstract

The host inflammatory response in cystic fibrosis (CF) lung disease has long been recognized as a central pathological feature and an important therapeutic target. Indeed, many believe that bronchiectasis results largely from the oxidative and proteolytic damage comprised within an exuberant airway inflammatory response that is dominated by neutrophils. In this review, we address the longstanding argument of whether or not the inflammatory response is directly attributable to impairment of the cystic fibrosis transmembrane conductance regulator or only secondary to airway obstruction and chronic bacterial infection and challenge the importance of this distinction in the context of therapy. We also review the centrality of neutrophils in CF lung pathophysiology and highlight more recent data that suggest the importance of other cell types and signaling beyond NF-κB activation. We discuss how protease and redox imbalance are critical factors in CF airway inflammation and end by reviewing some of the more promising therapeutic approaches now under development.

References

Dec 17, 1992·The New England Journal of Medicine·P A NixonC F Doershuk
Feb 16, 1991·Lancet·N G McElvaneyR G Crystal
Mar 1, 1990·The Journal of Clinical Investigation·C P SommerhoffG H Caughey
Jun 30, 1986·Biochemical and Biophysical Research Communications·M TsujimotoG Weissmann
Jan 1, 1988·Immunology Today·A Cerami, B Beutler
Sep 1, 1981·American Journal of Diseases of Children·P Van AsperenS J Simpson
Jan 1, 1995·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·A SchusterV Wahn
Apr 1, 1995·American Journal of Respiratory and Critical Care Medicine·T Z KhanD W Riches
Feb 1, 1995·Letters in Applied Microbiology·K T Elvers, S J Wright
Jun 17, 1995·BMJ : British Medical Journal·D S ArmstrongP D Phelan
Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·P BirrerR G Crystal
Oct 1, 1993·The American Review of Respiratory Disease·M W KonstanJ B Hilliard
Dec 1, 1995·American Journal of Respiratory and Critical Care Medicine·T L BonfieldM Berger
Nov 1, 1996·American Journal of Respiratory and Critical Care Medicine·P B DavisM W Konstan
Nov 1, 1996·American Journal of Respiratory and Critical Care Medicine·K K KirchnerF J Accurso
Oct 1, 1996·Archives of Disease in Childhood·I M Balfour-LynnR Dinwiddie
Mar 1, 1997·The Journal of Infectious Diseases·T L NoahM W Leigh
Mar 1, 1997·American Journal of Respiratory and Critical Care Medicine·D Y KollerI Eichler
May 6, 1999·American Journal of Respiratory and Critical Care Medicine·Y SatoS F van Eeden
May 6, 1999·American Journal of Respiratory and Critical Care Medicine·C MarguetJ O Warner
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·M S MuhlebachT L Noah
Jul 10, 1999·The Journal of Allergy and Clinical Immunology·T L BonfieldM Berger
Jun 15, 2000·The European Respiratory Journal·W H NikolaizikM H Schöni
Aug 2, 2000·American Journal of Respiratory Cell and Molecular Biology·R TirouvanziamE Puchelle
Aug 10, 2000·The Journal of Clinical Investigation·T J Kelley, H L Elmer
Sep 6, 2000·American Journal of Respiratory Cell and Molecular Biology·A VenkatakrishnanT S Blackwell
Feb 13, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·D KubeP B Davis
May 15, 2001·American Journal of Respiratory Cell and Molecular Biology·M J MhannaM A Haxhiu
Jun 19, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·A J WeberA Prince
Aug 14, 2001·American Journal of Respiratory and Critical Care Medicine·A HebestreitH Hebestreit

❮ Previous
Next ❯

Citations

Jul 7, 2016·Mediators of Inflammation·Andrea SchnúrGuido Veit
Jun 15, 2016·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Jonas EckrichOlaf Eickmeier
Jul 30, 2016·Pediatric Clinics of North America·Edith T Zemanick, Lucas R Hoffman
Dec 17, 2016·Proceedings of the National Academy of Sciences of the United States of America·Becca A FlitterJennifer M Bomberger
Nov 2, 2017·Journal of Cellular Biochemistry·Macarena Massip-CopizTomás A Santa-Coloma
Jul 18, 2017·Pediatric Pulmonology·Olivia Giddings, Charles R Esther
Dec 22, 2017·Expert Opinion on Emerging Drugs·Kristin M Hudock, John Paul Clancy
Aug 31, 2017·American Journal of Respiratory and Critical Care Medicine·Deepika PolineniMichael R Knowles
Jul 13, 2018·Pediatric Pulmonology·Erica A RoeschJames F Chmiel
Apr 25, 2018·American Journal of Respiratory and Critical Care Medicine·Scott D SagelMichele L Shaffer
May 4, 2018·American Journal of Respiratory Cell and Molecular Biology·Oliver J McElvaney, Noel G McElvaney
Nov 16, 2018·Proteomics. Clinical Applications·Emily M DeBoerRobin R Deterding
Mar 7, 2019·Pediatric Pulmonology·Elizabeth A ClarkeAlex Horsley
Feb 10, 2017·The European Respiratory Journal·Clifford TaggartKeren S Borensztajn
Mar 16, 2019·Cell Death & Disease·Valeria R VillellaLuigi Maiuri
Dec 1, 2018·The EMBO Journal·Valeria R VillellaLuigi Maiuri
Sep 12, 2019·Scientific Reports·Stefano CastellaniMassimo Conese
Nov 2, 2019·American Journal of Respiratory Cell and Molecular Biology·Steven T LeungSean V Murphy
Nov 13, 2019·Pediatric Pulmonology·Lucy Perrem, Felix Ratjen
Sep 6, 2019·Proceedings of the National Academy of Sciences of the United States of America·Qinheng ZhengK Barry Sharpless
Jun 13, 2020·Journal of Leukocyte Biology·Hang Pong NgGuoshun Wang
Jun 17, 2020·Expert Review of Respiratory Medicine·Claire J HoustonDamian G Downey
Jul 18, 2020·Journal of Leukocyte Biology·Keren B TurtonMiguel A Valvano
May 16, 2017·American Journal of Respiratory and Critical Care Medicine·Traci M Kazmerski, Gregory S Sawicki
Jan 11, 2019·Der Internist·Patience Eschenhagen, Carsten Schwarz
May 16, 2019·Revista paulista de pediatria : orgão oficial da Sociedade de Pediatria de São Paulo·Miriam Isabel Souza Dos Santos SimonPaulo José Cauduro Marostica
Feb 23, 2020·Biochemistry. Biokhimii︠a︡·O L VoroninaA L Gintsburg
Mar 23, 2019·Italian Journal of Pediatrics·Luigi MaiuriGuido Kroemer
Nov 9, 2019·Scientific Reports·Francesco R LulyPaola Del Porto
Feb 6, 2020·International Journal of Molecular Sciences·Alison M D HuntCatherine M Greene
May 14, 2020·International Journal of Molecular Sciences·Anna EspositoAnnalisa Guaragna
Aug 15, 2020·Frontiers in Cellular and Infection Microbiology·Alexander J CurrieAdilia Warris
Sep 25, 2017·Scientific Reports·Paul T KingPhilip G Bardin
Nov 28, 2018·Molecular Diagnosis & Therapy·Giulio Cabrini
Mar 16, 2019·Frontiers in Pharmacology·Iwona PrankeIsabelle Sermet-Gaudelus
Jul 25, 2019·Journal of Clinical Medicine·Laura M TrandafirElena Cojocaru
Nov 11, 2019·Respiratory Research·Chuyi ZhangZuoren Yu
Jun 16, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Nidhi Anil
Sep 6, 2020·International Journal of Molecular Sciences·Karen KeownClifford C Taggart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinics in Chest Medicine
John R McArdle, Jaideep S Talwalkar
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
André M CantinJames F Chmiel
© 2021 Meta ULC. All rights reserved